PennyStockSites.com

Atmel Corporation, Chelsea Therapeutics International Ltd., Alcatel Lucent Soci and Amarin Corporation Plc Featured on February 17th, 2014 from Pennystocksites.com

 
Repost This

Miami, FL -- (SBWIRE) -- 02/17/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Atmel Corporation (NASDAQ:ATML), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Alcatel Lucent Soci (NYSE:ALU) and Amarin Corporation plc (NASDAQ:AMRN).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://pennystocksites.com/

Atmel Corporation (NASDAQ:ATML), Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit (IC) products. The company’s Microcontrollers segment provides various proprietary and non-proprietary solutions, such as Atmel’s capacitive touch products, including maXTouch and QTouch, AVR 8-bit and 32-bit products, ARM-based products, Atmels 8051 8-bit products, as well as XSense products. Its Nonvolatile Memories segment offers serial interface electrically erasable programmable read-only memory, and electrically erasable programmable read-only and erasable programmable read-only memory devices; and products for military and aerospace applications. The company’s Radio Frequency and Automotive segment provides automotive electronics, as well as wireless and wired devices for industrial, consumer, and automotive applications. This segment also offers foundry services. Its Application Specific Integrated Circuit segment provides custom application specific ICs designed to meet specialized single-customer requirements of high performance devices in a range of specific applications. This segment provides hardware security for embedded digital systems; and products for military and aerospace applications, as well as develops application specific standard products for space applications, power management, and secure crypto memory products. The company sells its products directly, as well as through distributors to original equipment manufacturers. It has operations in the United States, Asia, Europe, South Africa, and Central and South America. Atmel Corporation was founded in 1984 and is headquartered in San Jose, California.

Get a Free Technical Analysis on Atmel Corporation (NASDAQ:ATML): http://pennystocksites.com/market-scan/?symbol=atml

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. It is primarily developing Northera (droxidopa), a therapeutic agent that is used for the treatment of symptomatic neurogenic orthostatic hypotension (Neurogenic OH) in patients with primary autonomic failure, dopamine-ß-hydroxylase, and deficiency and non-diabetic autonomic neuropathy. The company is also evaluating the potential therapeutic applications of droxidopa in reducing the frequency of falls in patients with Neurogenic OH associated with Parkinson’s disease, as well as other potentially norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, and adult attention deficit hyperactivity disorder. In addition, it engages in developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis, and for the treatment of multiple other autoimmune disorders, including psoriasis, Crohn’s disease, uveitis, ankylosing spondylitis, inflammatory bowel disease, cancer, and other immunological disorders. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Get a Free Technical Analysis on Chelsea Therapeutics International LTD (NASDAQ:CHTP): http://pennystocksites.com/market-scan/?symbol=chtp

Alcatel Lucent Soci (NYSE:ALU), Alcatel Lucent Société Anonyme provides Internet protocol (IP) and cloud networking, and ultra-broadband fixed and wireless access to service providers and their customers, enterprises, and institutions worldwide. It operates through three segments: Core Networking, Access, and Other. The Core Networking segment provides service routers and switches designed to support IP-based applications and services; and terrestrial optical products, which enable carriers to manage voice, data, and video traffic patterns based on various applications or platforms. It also develops, manufactures, installs, and maintains undersea telecommunications cable networks; and provides microwave radio products, as well as offers network build and implementation IP, platforms, and platforms professional services. The Access segment offers wireless products and services that enable mobile network operators to offer mobile data capacity; cable, antenna, tower systems, and their related electronic components; and fixed access products, which allow service providers to offer high speed broadband connectivity over copper and fiber connections. It also provides wireless and fixed network build and implementation, multivendor maintenance, licensing, and managed services. The Other segment offers communications and network solutions for businesses of various sizes to deliver collaborative conversations. This segment also serves communications needs of government agencies through building converged voice and network infrastructure for various governmental authorities. Alcatel Lucent Société Anonyme serves various industries, including power utilities, oil and gas, defense, public safety, state and local government, highways, and railways. The company was formerly known as Alcatel, S.A. and changed its name to Alcatel Lucent Société Anonyme in November 2006. The company was founded in 1898 and is headquartered in Paris, France.

Get a Free Technical Analysis on Alcatel Lucent Soci (NYSE:ALU): http://pennystocksites.com/market-scan/?symbol=alu

Amarin Corporation plc (NASDAQ:AMRN), Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.

Get a Free Technical Analysis on Amarin Corporation plc (NASDAQ:AMRN),: http://pennystocksites.com/market-scan/?symbol=amrn

Disclosure
We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.

Contact:
news@pennystocksites.com
http://pennystocksites.com/
http://pennystocksites.com/disclaimer/